SCHEMBL28298243

SCHEMBL28298243

COc1ccccc1-n1c(=O)[nH]c2cnc(N(C)C3CCCN3)nc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.38
KDM4E B2RXH2 4/20 0.37
ADORA2A P29274 2/20 0.37
GLA P06280 2/20 0.37
ALDH1A1 P00352 2/20 0.37
ATM Q13315 1/20 0.37
HPGD P15428 2/20 0.37
ADORA1 P30542 1/20 0.37
SLC2A1 P11166 1/20 0.36
SLC2A3 P11169 1/20 0.36
SIGMAR1 Q99720 2/20 0.36
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HCAR1 Q9BXC0 1/20 0.35
PDE9A O76083 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
TNKS O95271 2/20 0.35
TNKS2 Q9H2K2 2/20 0.35
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28298239 1.00 MAPT (0.38) MAPTKDM4EADORA2AGLAALDH1A1
SCHEMBL28299546 1.00 MAPT (0.38) MAPTKDM4EADORA2AGLAALDH1A1
SCHEMBL27988321 0.82 KDM4E (0.56) MAPTKDM4EGLAALDH1A1HPGD
SCHEMBL300896 0.82 KDM4E (0.56) MAPTKDM4EGLAALDH1A1HPGD
SCHEMBL301230 0.82 KDM4E (0.56) MAPTKDM4EGLAALDH1A1HPGD
SCHEMBL28299549 0.78 ADORA2A (0.44) KDM4EADORA2AHPGDADORA1SIGMAR1
SCHEMBL15205956 0.78 ADORA2A (0.44) KDM4EADORA2AHPGDADORA1SIGMAR1
SCHEMBL28298241 0.78 ADORA2A (0.44) KDM4EADORA2AHPGDADORA1SIGMAR1
SCHEMBL2322021 0.74 ADORA2A (0.51) KDM4EADORA2AHPGDADORA1
SCHEMBL29828788 0.74 ADORA2A (0.51) KDM4EADORA2AHPGDADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109846884-A With TOR kinase inhibitor for treating cancer 西格诺药品有限公司 2019-06-07 CN disclosed